United Therapeutics’ Tyvaso meets goals in PH-ILD patients
United Therapeutics’ Tyvaso is indicated to treat pulmonary arterial hypertension patients. Credit: Farragutful.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more